We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Dark Chocolate Reduces ACE Activity and May Lower Heart Attack Risk

By LabMedica International staff writers
Posted on 01 Dec 2010
Eating as little as 75 grams of dark chocolate reduces the activity of angiotensin-converting enzyme (ACE) while increasing levels of nitric oxide (NO), which suggests that including chocolate in the diet may ultimately help reduce hypertension and its related risk of cardiovascular disease.

Investigators at Linköping University (Sweden) wanted to determine if cocoa extract and dark chocolate would influence ACE and NO in human endothelial cells (in vitro) and in healthy volunteers (in vivo). More...


ACE activity was analyzed with a commercial radioenzymatic assay and measured in human endothelial cells from umbilical veins (HUVEC) after a 10-minute incubation with cocoa extract. NO was measured after 24 hours incubation. In 16 healthy volunteers ACE activity and NO were measured at baseline and after 30, 60 and 180 minutes after a single intake of 75 g dark chocolate containing 72% cocoa. The volunteers were not tobacco users and were not allowed to take any pharmaceuticals for the two weeks prior to the experiment. During the last two days, they were not allowed to eat chocolate or any foods containing similar compounds, including many kinds of berries and fruits, nor could they drink coffee, tea, or wine.

Results published in the October 14, 2010, online edition of the Journal of Cardiovascular Pharmacology revealed that in the HUVEC significant inhibition of ACE activity and significant increase of NO were seen. In the human volunteers, a significant inhibition of ACE activity (mean 18%) three hours after intake of dark chocolate was measured, but no significant change in NO was seen.

"We have previously shown that green tea inhibits the enzyme ACE, which is involved in the body's fluid balance and blood pressure regulation. Now we wanted to study the effect of cocoa, since the active substances catechins and procyanidines are related,” said first author Dr. Ingrid Persson, professor of pharmacology at Linköping University. "Our findings indicate that changes in lifestyle with the help of foods that contain large concentrations of catechins and procyaninides prevent cardiovascular diseases.”

Related Links:
Linköping University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Chromogenic Culture System
InTray™ COLOREX™ ECC
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.